Bert De Jong, MD, Ffpm
About Bert De Jong, MD, Ffpm
Bert De Jong, MD, Ffpm, is the Global Lead Thoracic Oncology Medical Affairs at Novocure, with over 20 years of experience in clinical research, development, and medical affairs across multiple therapeutic areas.
Title
Bert De Jong, MD, Ffpm, serves as the Global Lead Thoracic Oncology Medical Affairs at Novocure.
Professional Experience at Novocure
Bert De Jong currently holds the position of Global Lead Thoracic Oncology Medical Affairs at Novocure. His role involves overseeing medical affairs pertaining to thoracic oncology on a global scale.
Past Role at Novartis Global Oncology
From 2015 to 2021, Bert De Jong worked as the Global Group Medical Director Lung and Established Products at Novartis Global Oncology in the Basel Area, Switzerland. During his six-year tenure, he played a pivotal role in managing medical strategies and operations for lung-related treatments and established products.
Education and Academic Background
Bert De Jong achieved his M.D. from Erasmus University Rotterdam between 1986 and 1988 after completing his Master's in Medicine at the University of Amsterdam from 1978 to 1986. Additionally, he holds a Certificate of Professional Development from The Wharton School through the Wharton/Windhover Program for Pharmaceutical and Biotech Executives.
Extensive Experience in Medical Affairs
Bert De Jong has over 20 years of experience in clinical research, development, medical affairs, market access, and commercialization of pharmaceuticals. His career includes roles at prestigious organizations such as GSK Biologicals, ENDO Pharmaceuticals Inc., Organon USA, The Medicines Company, Centocor, Rhone-Poulenc Rorer, and SmithKlineBeecham.
Multilingual Proficiency
Bert De Jong is fluent in English, Dutch, French, and German, enabling him to operate effectively in diverse, cross-cultural environments.